Search

Search Results

• PO:15:222 | Post-hoc analysis of the BeRLiSS-JS registry: efficacy of belimumab on thrombocytopenia Greta Hulej¹, Margherita Zen¹, Marisol Bracalenti¹, Francesca Bottazzi², Rossella De Angelis³, Giacomo Emmi⁴, Roberto Gerli⁵, Marcello Govoni⁶, Renato Lo Gullo⁷, Simone Negrini⁸, Luca Quartuccio⁹, Maurizio Rossini¹⁰, Carlo Salvarani¹¹, Paola Tomietto⁴, Angelo Vacca¹², Andrea Doria¹, Luca Iaccarino¹. | ¹Università degli Studi di Padova, Padova, Italy; ²Università degli Studi di Pavia, Pavia, Italy; ³Università Politecnica delle Marche, Ancona, Italy; ⁴Università degli Studi di Trieste, Trieste, Italy; ⁵Università degli Studi Perugia, Perugia, Italy; ⁶Università degli Studi di Ferrara, Ferrara, Italy; ⁷Università degli Studi di Catania, Catania, Italy; ⁸Università degli Studi di Torino, Torino, Italy; ⁹Università degli Studi di Udine, Udine, Italy; ¹⁰Università degli Studi di Verona, Verona, Italy; ¹¹Università degli Studi di Modena e Reggio Emilia, Modena, Italy; ¹²Università degli Studi di Bari .

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2042

  174

• PO:16:227 | Anifrolumab for Systemic Lupus Erythematosus: Preliminary Safety and Efficacy Findings from the Italian Experience Paola Bizioli^1|2, Chiara Orlandi^1|2, Claudia Barison^1|2, Cesare Tomasi³, Alessia Caproli¹, Silvia Piantoni^1|2, Simona Signorini⁴, Emirena Garrafa⁴, Cecilia Nalli¹, Micol Frassi¹, Ilaria Cavazzana^1|2, Micaela Fredi^1|2, Franco Franceschini^1|2 | ¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia, Italy; ³Department of Clinical and Experimental Sciences, University of Brescia, Italy; ⁴Laboratory of Clinical Chemistry, Department of Molecular and Translational Medicine, University of Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2333

  77
• 

  Pseudo-pseudo Meigs’ syndrome: a rare presentation of systemic lupus erythematosus

  G. Tansir, P. Kumar, A. Pius, S.K. Sunny, M. Soneja

  108-112

  09-07-2019

  https://doi.org/10.4081/reumatismo.2019.1140

  2295

  PDF: 1450
• 

  Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

  C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

  91-96

  https://doi.org/10.4081/reumatismo.2011.91

  1616

  PDF: 850

• PO:15:218 | Evaluation of leukocyte expression of ecto-nucleotidase in patients with systemic lupus erythematosus Luca Rapino¹, Simona Truglia¹, Fulvia Ceccarelli¹, Francesca Romana Spinelli¹, Silvia Mancuso¹, Giada La Spina¹, Hector Rincon Arvalo², Thomas Doerner², Ana Luisa Stefanski², Fabrizio Conti¹. | ¹La Sapienza Università di, Roma, - Dipartimento di Scienze Cliniche Internistiche Anestesiologiche e Cardiovascolare, Roma, Italy; ²Charité Universitätsmedizin - Department of Rheumatology and Clinical Immunology, Berlino, Germany.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2038

  158
• 

  Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience

  Carmela Coccia, Gemma Lepri, Juela Levani, Silvia Bellando Randone, Serena Guiducci

  04-08-2025

  https://doi.org/10.4081/reumatismo.2025.1853

  1405

  PDF: 221

• PO:14:199 | Preliminary data of a multicentric study on safety and efficacy of assisted reproductive techniques in pregnant women with systemic autoimmune diseases Valentina Canti¹, Maria Bernadette Cilona¹, Giuditta Gorgone¹, Federica Pasi¹, Antonia Calligaro², Francesca Ruffilli³, Francesca Crisafulli⁶, Maria Tonello², Eleonora Giacobbe⁴, Alba Chiara Pozzi⁶, Maria Chiara Gerardi⁴, Melissa Padovan³, Emanuele Bizzi⁵, Enrico Papaleo¹, Beatrice Maranini³, Marcello Govoni³, Massimiliano Epis⁴, Angela Tincani⁶, Andrea Doria², Patrizia Rovere Querini¹ | ¹IRCCS Ospedale San Raffaele and VitaSalute San Raffaele Milano, Italy; ²Rheumatology Unit, Departement of Medicine, University Hospital of Padua Padova, Italy; ³Rheumatology Unit, Azienda Ospedaliero Universitaria S. Anna Ferrara, Department of Medical Sciences, University of Fe Ferrara, Italy; ⁴ASST Grande Ospedale Metropolitano Niguarda Milano, Italy; ⁵Internal Medicine, Fatebenefratelli Hospital Milano, Italy; ⁶Rheumatology and Immunology Unit, ASST Spedali Civili Brescia e Università degli Studi di Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2322

  40
• 

  Adherence to cervical cancer screening in an Italian SLE cohort

  C. Tani, L. Carli, M. Mosca, C. Baldini, A. Consensi, M. Doveri, R. Talarico, S. Bombardieri

  11-17

  https://doi.org/10.4081/reumatismo.2011.11

  1469

  PDF: 909

• Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience

  L. Cometi, P. Francesconi, B. Bellini, L. Turco, F. Voller, F. Nacci, S. Bellando-Randone, M. Matucci-Cerinic, S. Guiducci

  22-03-2024

  https://doi.org/10.4081/reumatismo.2024.1547

  1154

  PDF: 643

• PO:14:204 | Risk stratification in systemic lupus erythematosus patients: improving the performances of a prediction model Lucia Lanzo¹, Silvia Laura Bosello¹, Livia Lilli², Laura Antenucci², Carlotta Masciocchi², Marco Gorini³, Gabriella Castellino³, Luca Petricca¹, Maria Rita Gigante¹, Vivianaantonella Pacucci¹, Pier Giacomo Cerasuolo¹, Silvia Piunno¹, Francesco Cristiano¹, Cesare Gavotti¹, Pier Luigi Rizzuti¹, Rebecca Ventura¹, Jacopo Lenkowicz², Alfredo Cesario², Stefano Patarnello², Maria Antonietta D'Agostino¹. | ¹UOC di Reumatologia e Immunologia clinica - Fondazione Policlinico Universitario A. Gemelli IRCSS, UCSC, Roma, Italy; ²Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma, Italy; ³AstraZeneca MIND, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2033

  194

• PO:12:187 | Maternal Hypertensive Disorders in Pregnant Women with Rheumatic Diseases and long-term Cardiovascular Outcomes: preliminary data of a single centre experience Margherita Rinaldi¹, Paolo Semeraro¹, Francesca Crisafulli¹, Matteo Filippini², Maria Grazia Lazzaroni¹, Cecilia Nalli¹, Liala Moschetti¹, Marco Taglietti², Chiara Loardi³, Rossana Orabona³, Francesca Ramazzotto³, Sonia Zatti³, Laura Andreoli¹, Angela Tincani¹, Micaela Fredi¹, Ilaria Cavazzana¹, Franco Franceschini¹ | ¹Department of Clinical and Experimental Sciences, University of Brescia, Italy; ²Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, ERN-ReCONNET Center Brescia, Italy; ³Gynaecology and Obstetrics Unit ASST Spedali Civili di Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2317

  66

• BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity

  M. Vadacca, D. Margiotta, D. Sambataro, F. Buzzulini, M. Lo Vullo, A. Rigon, A. Afeltra

  259-265

  https://doi.org/10.4081/reumatismo.2010.259

  2122

  PDF: 2406
• 

  Anti-N-methyl-d-aspartate receptor encephalitis: mimicker of lupus and multiple sclerosis

  N. Sanghavi, B. Ayesha

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1598

  1986

  PDF: 636

• PO:14:194 | The CORAL Study: Complement levels during pregnancy in prospectively followed systemic Lupus erythematosus patients Irene Cecchi¹, Massimo Radin¹, Alice Barinotti¹, Francesca Crisafulli², Laura Andreoli², Cecilia Beatrice Chighizola³, Savino Sciascia¹, On Behalf Of The Coral Study Group¹ | ¹Università di Torino, Italy; ²Università di Brescia, Italy; ³Università di Milano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2319

  37

• The main stages in the history of systemic lupus erythematosus

  M. Rampudda, P. Marson, G. Pasero

  145-152

  https://doi.org/10.4081/reumatismo.2009.145

  2169

  PDF: 2076

• Systemic lupus erythematosus: the first italian prevalence study

  M. Benucci, F. Li Gobbi, A. Del Rosso, M. Manfredi

  103-108

  https://doi.org/10.4081/reumatismo.2005.103

  1504

  PDF: 1508
• 

  Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome

  V. Bruzzese, P. Scolieri, J. Pepe

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1431

  5974

  PDF: 830

• Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR+CD25- cell subset in patients with systemic lupus erythematosus

  A. Alunno, G. Nocentini, O. Bistoni, R. Bianchini, E. Bartoloni Bocci, C. Riccardi, R. Gerli

  195-201

  https://doi.org/10.4081/reumatismo.2010.195

  1413

  PDF: 954
• 

  Jaccoud’s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment

  M. Benucci, A. Damiani, F. Li Gobbi, V. Grossi, M. Infantino, A. Arena, M. Manfredi

  88-91

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.968

  2463

  PDF: 1166

• Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?

  L. Andreoli, F. Pregnolato, R.W. Burlingame, V. Fanelli, F. Allegri, A. Radice, C. Corace, R.A. Sinico, A. Tinconi, P.L. Meroni

  185-191

  https://doi.org/10.4081/reumatismo.2008.185

  1267

  PDF: 1163

• PO:15:214 | Identification of SLE patients with high-levels Type 2 SLE through the polysymptomatic distress scale (PSD): correlations with other PROs and differences in clinical phenotypes in a multicentric cohort Micaela Fredi^1|2, Giorgia Gozzoli^1|2, Federica Bonaso^1|2, Silvia Ebe Della Pina^1|2, Claudia Barison^1|2, Irene Lorenzini², Anna Mattiuzzo², Raffaele Pericotti², Marcelo Neto³, Sofia Avedo⁴, Clàudia Oliveira⁴, Luis Sousa Ines³, Franco Franceschini^1|2 | ¹Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, ERN-ReCONNET Center, Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; ³Rheumatology Department, Centro Hospitalar Universitário de Coimbra - ULS Coimbra, Coimbra, Portugal; ⁴Rheumatology Department, ULS Aveiro, Aveiro, Portugal

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2327

  35

• PO:17:250 | Effectiveness and safety of the recombinant zoster vaccine in patients ≥18 years of age with systemic lupus Giulia Boschi¹, Sheryl A. Kluberg², Sophie E. Mayer², O'Mareen Spence³, Driss Oraichi³, Harry Seifert³, Omar Ali³, Huifeng Yun³, Andrew L. Simon⁴, Jenice S. Ko⁴, Caroline Hugh⁴, Meg Her⁴, Kathleen Shattuck⁴, Richard Platt², Aziza Jamal-Allial⁵, Djeneba Audrey Djibo⁶, Kimberly Daniels⁵, Qianli Ma⁷, Cheryl N. Mcmahill-Walraven⁶, Rachel P. Ogilvie⁸, Kristin Palmsten⁹, Mano Selvan⁷, Najat Ziyadeh⁸, Alexis Ogdie¹⁰, Michael George¹⁰ | ¹GSK Verona Italy; ²Harvard Medical School and the Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; ³GSK Rockville; ⁴Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; ⁵Carelon Research, Wilmington; ⁶CVS Health, Blue Bell; ⁷Humana Healthcare Research, Louisville; ⁸OptumInsight Life Sciences, Boston; ⁹HealthPartners Institute, Bloomington; ¹⁰University of Pennsylvania, Philadelphia, USA

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2166

  171

• The evaluation of neuropsychiatric lupus erythematosus by functional neuroimaging. Preliminary results

  M. Padovan, A. Locaputo, N. Rizzo, M. Govoni, F. Trotta

  24-30

  https://doi.org/10.4081/reumatismo.2004.24

  1571

  PDF: 3229

• PO:08:114 | The adjuvanted recombinant zoster vaccine is effective in preventing herpes zoster among patients ≥50 years of age with selected autoimmune diseases in the united states: a real-world database analysis (2018–2021) Rosaria Silvestri¹, Dagna Constenla², Germain Lonnet³, Emmanuel Aris³, Nathalie Servotte³, Ramsanjay Rk⁴, Agnes Mwakingwe-Omari², Huifeng Yun² | ¹GSK Verona, Italy; ²GSK Rockville, USA; ³GSK Wavre, Belgium; ⁴GSK Bengaluru, India

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2140

  210

• Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases

  C. Sales, F. Oliviero, P. Spinella

  95-101

  https://doi.org/10.4081/reumatismo.2008.95

  2977

  PDF: 1945

• PO:11:171 | Subcutaneous tocilizumab use in a young-onset mixed connective tissue disease patient with multiple treatment failures Rhaysa Araujo Mousinho¹, Elide Lupi², Massimiliano Limonta² | ¹Clinica di Reumatologia, Dipartimento di Medicina and ²Istituto di Anatomia Patologica, Dipartimento di Medicina di Laboratorio, Osp. S. M. della Misericordia, Università di Udine, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2154

  195
• 

  Serum KL-6 as predictive and prognostic marker of interstitial lung disease in childhood connective tissue diseases: a pilot study

  R. El-Beheidy, A.M. Domouky, H. Zidan, Y.A. Amer

  22-11-2021

  https://doi.org/10.4081/reumatismo.2021.1399

  7282

  PDF: 1176

• PO:37:267 | Mimickers of polyarteritis nodosa: a case of segmental arteriolar mediolysis Filippo Santoro¹, Caterina Vacchi², Giulia Cassone², Maria Grazia Malandra¹, Dilia Giuggioli^1|2 | ¹UOSD Reumatologia, Ospedale San Camillo De Lellis, Rieti; ²UOC Igiene e Sanità Pubblica, ASL Rieti; ³Direzione Sanitaria, ASL Rieti, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2221

  200

• Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations

  A. Tincani, C. Casu, S. Cartella, T. Ziglioli, R. Cattaneo

  65-75

  https://doi.org/10.4081/reumatismo.2010.65

  1968

  PDF: 3264

• Thalidomide in treatment of connective diseases and vasculities

  N. Maruotti, F.P. Cantatore, D. Ribatti

  187-190

  https://doi.org/10.4081/reumatismo.2006.187

  1605

  PDF: 1300

• Possible role of Hsp70 in autoantigens shuttling to dermo-epidermal junction in systemic lupus erythematosus

  R. Villalobos-Hurtado, S.H. Sánchez-Rogriguez, E. Avalos-Díaz, R. Herrera-Esparza

  155-158

  https://doi.org/10.4081/reumatismo.2003.155

  993

  PDF: 950

• PO:02:024 | Development of anti-drug antibodies in patients with peripheral and/or axial spondyloarthritis treated with infliximab or adalimumab: a monocentric cross-sectional study Gabriele Amati¹, Gilda Sandri^1|2, Alessandra Melegari³, Benedetta Bongiovanni^1|2, Giovanni Ciancio², Martina Orlandi^1|2, Ottavio Secchi¹, Dilia Giuggioli^1|2 | ¹Struttura complessa di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena; ²Cattedra di Reumatologia, Università degli studi di Modena e Reggio Emilia; ³Dipartimento di medicina di laboratorio, Ospedale di Baggiovara, AUSL di Modena, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2126

  184

• Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

  M.G. Portuesi, P. Perosa

  61-63

  https://doi.org/10.4081/reumatismo.2008.61

  1334

  PDF: 966
• 

  A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools

  S. Pirri, R. Talarico, D. Marinello, G. Turchetti, M. Mosca

  22-11-2021

  https://doi.org/10.4081/reumatismo.2021.1418

  6662

  PDF: 990

• Isolated congenital heart block in undifferentiated connective tissue disease and in primary Sjögren’s syndrome: a clinical study of 81 pregnancies in 41 patients

  C. Grava, A. Ruffatti, O. Milanesi, M. Favaro, M. Tonello, A. Calligaro, T. Del Ross, S. Todesco

  180-186

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.180

  1418

  PDF: 4106

• PO:25:083 | Overlap between Sjögren’s syndrome and lichen sclerosus: beyond coincidence? Emanuele Giovanni Grilli¹, Ludovica Manisera¹, Ilenia Fischetti¹, Linda Mastromanno¹, Martina Villa¹, Angelica Gattamelata¹, Fabrizio Conti¹, Roberta Priori^1|2, Serena Colafrancesco^3|4 | ¹Dipartimento di Medicina e Chirurgia, Università Milano-Bicocca; ²U.O. Reumatologia, IRCCS Fondazione San Gerardo dei Tintori, Monza; ³U.O. Pneumologia, IRCCS Fondazione San Gerardo dei Tintori, Monza; ⁴Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS Humanitas Research Hosp, Rozzano, Milano, Italy 

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2192

  244

• Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients

  S. Cuffaro, T. Del Ross, M. Tonello, A. Bontadi, S. Olivieri, E. Salvan, A. Ruffatti, L. Punzi

  51-59

  https://doi.org/10.4081/reumatismo.2010.51

  1643

  PDF: 845

• Multiple Sclerosis and autoimmune diseases: clinical cases and review of the literature

  G. Castellino, A. Protti, B. Canesi

  196-203

  https://doi.org/10.4081/reumatismo.2001.196

  1146

  PDF: 5381

• PO:21:021 | The eyes tell the story: a clinical case of Rosah syndrome Nicolò Sabbion¹, Sofia Vitale¹, Claudia Balicchia¹, Barbara Troise¹, Francesca Mascia¹, Eleonora Bassanello², Jacopo Croce², Federica Maiolini², Filippo Mazzi², Elisa Tinazzi², Francesca Bosello¹, Simonetta Friso¹, Lucia De Franceschi¹ | ¹Università degli Studi di Verona; ²Azienda Ospedaliera Universitaria Integrata, Verona, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2180

  307
• 

  Kikuchi-Fujimoto disease with multiple extra-nodal features - A clinical mimic

  C.A. Mansoor, Z. Shemin

  105-107

  09-07-2019

  https://doi.org/10.4081/reumatismo.2019.1130

  1794

  PDF: 1032

• Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis

  M. Vadacca, R. Bruni, F. Caccipaglia, F. Serino, L. Arcarese, F. Buzzulini, G. Coppolino, A. Rigon, N. Terminio, A. Afeltra

  50-56

  https://doi.org/10.4081/reumatismo.2008.50

  2099

  PDF: 1220

• PO:14:202 | Use of anifrolumab in the treatment of the hematological manifestations of systemic lupus erythematosus: a single-centre case series Gaia Ferracane^1|2, Jessika Dichiara^1|2, Elena Manna^1|2, Lorenzo Mattia Bianchessi^1|2, Giovanni Zanframundo^1|2, Serena Bugatti^1|2, Veronica Codullo^1|2, Lorenzo Cavagna^1|2, Francesca Bottazzi^1|2 | ¹Department of Internal Medicine and Therapeutics, Università di Pavia; ²Division of Rheumatology, IRCCS Policlinico San Matteo, Pavia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2159

  285

• Pulmonary hypertension in autoimmune rheumatic diseases

  B. Marasini, M. Massarotti, R. Cossutta, L. Massironi, A. Mantero

  114-118

  https://doi.org/10.4081/reumatismo.2005.114

  1043

  PDF: 2840
• 

  Peripheral neuropathy in antiphospholipid syndrome: a systematic review

  Rafael Reis do Espírito Santos, Cezar Augusto Muniz Caldas, Jozélio Freire de Carvalho

  03-06-2025

  https://doi.org/10.4081/reumatismo.2025.1735

  3274

  PDF: 591

• Malar rash in a painting by Jean-Baptiste Siméon Chardin (1699-1779)

  P. Marson, R. Rondinone, M. Vicarioto

  175-179

  https://doi.org/10.4081/reumatismo.2001.175

  1457

  PDF: 955

• Metabolic syndrome in inflammatory rheumatic diseases

  D. Malesci, G. Valentini, G. La Montagna

  169-176

  https://doi.org/10.4081/reumatismo.2006.169

  1971

  PDF: 4006
• 

  Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis

  D.J. Manzella, L. Vicente, A.A. Pérez de la Hoz, R.J. Zamora, G. De Rosa, A.A. Pisarevsky

  92-98

  09-07-2019

  https://doi.org/10.4081/reumatismo.2019.1095

  1653

  PDF: 1143

• Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting

  A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari

  324-330

  https://doi.org/10.4081/reumatismo.2002.324

  1060

  PDF: 2761

• Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”

  M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri

  35-40

  https://doi.org/10.4081/reumatismo.2008.35

  2158

  PDF: 1637

• PO:15:217 | Improved efficacy and safety outcomes in patients with systemic lupus erythematosus treated with belimumab vs. immunosuppressants, in addition to antimalarials and glucocorticoids: a post-hoc summary of five phase 3 trials Mariele Gatto¹, Karen H. Costenbader², Andreas Schwarting³, Julia Hn Harris⁴, Ciara O'Shea⁵, Roger A. Levy⁶, Andrea Doria⁷ | ¹Centro Accademico Reumatologia, Dipartimento Scienze Cliniche Biologiche, Università degli Studi Torino, Osp. Mauriziano, Italy; ²Brigham and Women's Hospital, Divisione di Reumatologia, Infiammazione e Immunità, Harvard Medical School, Boston, MA, USA; ³Università Johannes Gutenberg di Mainz, Centro medico universitario, Germany; ⁴GSK, Immunologia Biostatistica London, UK; ⁵GSK, Global Medical Affairs Reumatologia, Dublin, Ireland; ⁶GSK, Global Medical Affairs Collegeville, PA, USA; ⁷Divisione di Reumatologia, Dipartimento di Medicina, Università di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2160

  191